Capiri-sutent Phase-1 in Advanced Colo-rectal Cancer


NCT00777478

Interventional

Phase 1

Unknown status
sutent-capiri
The primary objective of this Phase 1 study is to identify the recommended dose of capiri and of sunitinib for combination therapy subsequent phase II trials.
Dec 31,2008
All
18 Years
N/A
32

In order to facilitate the use of our website, we use cookies.

Please confirm if you accept our tracking cookies. When declining the cookies, you can continue visiting the website without sending data to third party services. Read our complete cookie statement here.